Containing the costs of managing hypertension

Med J Aust. 2001 Jun 4;174(11):556-7. doi: 10.5694/j.1326-5377.2001.tb143432.x.
No abstract available

Publication types

  • Editorial
  • Review
  • Comment

MeSH terms

  • Adrenergic beta-Antagonists / economics*
  • Antihypertensive Agents / economics*
  • Benzothiadiazines*
  • Bias
  • Calcium Channel Blockers / economics*
  • Cost Control
  • Diuretics
  • Drug Costs / statistics & numerical data*
  • Drug Industry
  • Drug Utilization
  • Humans
  • Hypertension / drug therapy*
  • Hypertension / economics*
  • Renin-Angiotensin System / drug effects
  • Sodium Chloride Symporter Inhibitors / economics*
  • South Africa

Substances

  • Adrenergic beta-Antagonists
  • Antihypertensive Agents
  • Benzothiadiazines
  • Calcium Channel Blockers
  • Diuretics
  • Sodium Chloride Symporter Inhibitors